Cargando…
New Trends in Aging Drug Discovery
Aging is considered the main risk factor for many chronic diseases that frequently appear at advanced ages. However, the inevitability of this process is being questioned by recent research that suggests that senescent cells have specific features that differentiate them from younger cells and that...
Autores principales: | Benhamú, Bellinda, Martín-Fontecha, Mar, Vázquez-Villa, Henar, López-Rodríguez, María L., Ortega-Gutiérrez, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405986/ https://www.ncbi.nlm.nih.gov/pubmed/36009552 http://dx.doi.org/10.3390/biomedicines10082006 |
Ejemplares similares
-
A new serotonin 5-HT(6) receptor antagonist with procognitive activity – Importance of a halogen bond interaction to stabilize the binding
por: González-Vera, Juan A., et al.
Publicado: (2017) -
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
por: Puig, Teresa, et al.
Publicado: (2011) -
The Search for Antibacterial Inhibitors Targeting Cell Division Protein FtsZ at Its Nucleotide and Allosteric Binding Sites
por: Andreu, José M., et al.
Publicado: (2022) -
Discovery of V-0219:
A Small-Molecule Positive
Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
toward Oral Treatment for “Diabesity”
por: Decara, Juan M., et al.
Publicado: (2022) -
Targeting the FtsZ Allosteric Binding Site with a
Novel Fluorescence Polarization Screen, Cytological and Structural
Approaches for Antibacterial Discovery
por: Huecas, Sonia, et al.
Publicado: (2021)